-
PMCB Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
PharmaCyte Biotech (PMCB)
Company Profile
Quarter (USD) | Oct 24 | Jul 24 | Apr 24 | Jan 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Apr 24 | Apr 23 | Apr 22 | Apr 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 20.84 mm | 20.84 mm | 20.84 mm | 20.84 mm | 20.84 mm | 20.84 mm |
Cash burn (monthly) | 3.93 mm | 4.38 mm | 368.69 k | 617.51 k | 351.58 k | 161.51 k |
Cash used (since last report) | 11.79 mm | 13.14 mm | 1.11 mm | 1.85 mm | 1.05 mm | 484.19 k |
Cash remaining | 9.05 mm | 7.70 mm | 19.73 mm | 18.99 mm | 19.79 mm | 20.36 mm |
Runway (months of cash) | 2.3 | 1.8 | 53.5 | 30.8 | 56.3 | 126.0 |
13F holders | Current |
---|---|
Total holders | 21 |
Opened positions | 2 |
Closed positions | 11 |
Increased positions | 2 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 1.05 bn |
Total shares | 1.51 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Ayrton Capital | 956.23 k | $2.15 mm |
Vanguard | 192.39 k | $367.46 mm |
Geode Capital Management | 168.20 k | $321.29 mm |
Equitec Proprietary Markets | 82.73 k | $158.01 mm |
Renaissance Technologies | 49.70 k | $94.93 mm |
Dimensional Fund Advisors | 27.60 k | $52.72 mm |
NTRS Northern Trust | 19.21 k | $36.69 mm |
UBS UBS | 8.35 k | $15.96 mm |
Acadian Asset Management | 2.85 k | $5.00 k |
Aspire Private Capital | 800.00 | $1.53 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Apr 24 | Schechter Jonathan | Stock Option Common Stock | Grant | Acquire A | No | No | 2.12 | 38,009 | 80.58 k | 38,009 |
30 Apr 24 | Wayne Remell Walker | Stock Option Common Stock | Grant | Acquire A | No | No | 2.12 | 38,009 | 80.58 k | 38,009 |
30 Apr 24 | Michael M Abecassis | Stock Option Common Stock | Grant | Acquire A | No | No | 2.12 | 38,009 | 80.58 k | 38,009 |
30 Apr 24 | Weinstein Robert | Stock Option Common Stock | Grant | Acquire A | No | No | 2.12 | 38,009 | 80.58 k | 38,009 |